178 related articles for article (PubMed ID: 37973560)
1. PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.
Wang Y; Wang C; Guan X; Ma Y; Zhang S; Li F; Yin Y; Sun Z; Chen X; Yin H
Adv Sci (Weinh); 2023 Dec; 10(36):e2303812. PubMed ID: 37973560
[TBL] [Abstract][Full Text] [Related]
2. Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.
Lei Y; Han P; Chen Y; Wang H; Wang S; Wang M; Liu J; Yan W; Tian D; Liu M
Clin Transl Med; 2022 Jan; 12(1):e686. PubMed ID: 35090076
[TBL] [Abstract][Full Text] [Related]
3. Decreased nitric oxide content mediated by asymmetrical dimethylarginine and protein l-arginine methyltransferase 3 in macrophages induces trophoblast apoptosis: a potential cause of recurrent miscarriage.
Hao F; Tang LC; Sun JX; Li WX; Zhao Y; Xu XH; Jin LP
Hum Reprod; 2021 Nov; 36(12):3049-3061. PubMed ID: 34647126
[TBL] [Abstract][Full Text] [Related]
4. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
[TBL] [Abstract][Full Text] [Related]
5. A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).
Kaniskan HÜ; Szewczyk MM; Yu Z; Eram MS; Yang X; Schmidt K; Luo X; Dai M; He F; Zang I; Lin Y; Kennedy S; Li F; Dobrovetsky E; Dong A; Smil D; Min SJ; Landon M; Lin-Jones J; Huang XP; Roth BL; Schapira M; Atadja P; Barsyte-Lovejoy D; Arrowsmith CH; Brown PJ; Zhao K; Jin J; Vedadi M
Angew Chem Int Ed Engl; 2015 Apr; 54(17):5166-70. PubMed ID: 25728001
[TBL] [Abstract][Full Text] [Related]
6. Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648.
Min Z; Xiaomeng L; Zheng L; Yangge D; Xuejiao L; Longwei L; Xiao Z; Yunsong L; Ping Z; Yongsheng Z
Cell Death Dis; 2019 Aug; 10(8):581. PubMed ID: 31378783
[TBL] [Abstract][Full Text] [Related]
7. PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.
Liao Y; Luo Z; Lin Y; Chen H; Chen T; Xu L; Orgurek S; Berry K; Dzieciatkowska M; Reisz JA; D'Alessandro A; Zhou W; Lu QR
Cell Death Dis; 2022 Nov; 13(11):943. PubMed ID: 36351894
[TBL] [Abstract][Full Text] [Related]
8. Arginine methylation of METTL14 promotes RNA N
Liu X; Wang H; Zhao X; Luo Q; Wang Q; Tan K; Wang Z; Jiang J; Cui J; Du E; Xia L; Du W; Chen D; Xia L; Xiao S
Nat Commun; 2021 Jun; 12(1):3780. PubMed ID: 34145242
[TBL] [Abstract][Full Text] [Related]
9. PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Shi Y; Niu Y; Yuan Y; Li K; Zhong C; Qiu Z; Li K; Lin Z; Yang Z; Zuo D; Qiu J; He W; Wang C; Liao Y; Wang G; Yuan Y; Li B
Nat Commun; 2023 Apr; 14(1):1932. PubMed ID: 37024475
[TBL] [Abstract][Full Text] [Related]
10. Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers.
Hsu SH; Hung WC
Cancer Lett; 2023 Feb; 554():216008. PubMed ID: 36400311
[TBL] [Abstract][Full Text] [Related]
11. Zebrafish prmt3 negatively regulates antiviral responses.
Zhu J; Liu X; Cai X; Ouyang G; Zha H; Zhou Z; Liao Q; Wang J; Xiao W
FASEB J; 2020 Aug; 34(8):10212-10227. PubMed ID: 32643209
[TBL] [Abstract][Full Text] [Related]
12. Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer.
Hsu MC; Tsai YL; Lin CH; Pan MR; Shan YS; Cheng TY; Cheng SH; Chen LT; Hung WC
J Hematol Oncol; 2019 Jul; 12(1):79. PubMed ID: 31324208
[TBL] [Abstract][Full Text] [Related]
13. PRMT1 methylates METTL14 to modulate its oncogenic function.
Wang J; Wang Z; Inuzuka H; Wei W; Liu J
Neoplasia; 2023 Aug; 42():100912. PubMed ID: 37269817
[TBL] [Abstract][Full Text] [Related]
14. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.
Singh V; Miranda TB; Jiang W; Frankel A; Roemer ME; Robb VA; Gutmann DH; Herschman HR; Clarke S; Newsham IF
Oncogene; 2004 Oct; 23(47):7761-71. PubMed ID: 15334060
[TBL] [Abstract][Full Text] [Related]
15. m
Wang Z; Pan Z; Adhikari S; Harada BT; Shen L; Yuan W; Abeywardana T; Al-Hadid Q; Stark JM; He C; Lin L; Yang Y
EMBO J; 2021 Mar; 40(5):e106309. PubMed ID: 33459381
[TBL] [Abstract][Full Text] [Related]
16. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation.
Tang J; Gary JD; Clarke S; Herschman HR
J Biol Chem; 1998 Jul; 273(27):16935-45. PubMed ID: 9642256
[TBL] [Abstract][Full Text] [Related]
17. Profiling substrates of protein arginine N-methyltransferase 3 with S-adenosyl-L-methionine analogues.
Guo H; Wang R; Zheng W; Chen Y; Blum G; Deng H; Luo M
ACS Chem Biol; 2014 Feb; 9(2):476-84. PubMed ID: 24320160
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
[TBL] [Abstract][Full Text] [Related]
19. PRMT3 is a distinct member of the protein arginine N-methyltransferase family. Conferral of substrate specificity by a zinc-finger domain.
Frankel A; Clarke S
J Biol Chem; 2000 Oct; 275(42):32974-82. PubMed ID: 10931850
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal protein S2 is a substrate for mammalian PRMT3 (protein arginine methyltransferase 3).
Swiercz R; Person MD; Bedford MT
Biochem J; 2005 Feb; 386(Pt 1):85-91. PubMed ID: 15473865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
